trial

Repetitive Transcranial Magnetic Stimulation (rTMS) Self-Referential Processing (rTMS-SRP)

NCTId NCT04068857
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Withdrawn
Enrollment 0 (actual)
Sponsored by Indiana University
Primary completion 2020-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2019-09
Primary completion
2020-12
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
rTMS

Sponsors

Indiana UniversityLead Sponsor

Investigators

1
Michael Francis, MDPrincipal Investigator

Sites

2 total
Indianapolis, United StatesIndianapolis, United States

Facts & assertions

4 sourced
Enrollment
0
Phase
NA
Primary Completion Date
2020-12
Status
WITHDRAWN
relationships
The graph out of here
drug
rTMS
drug
lead_sponsor
Indiana University
company
indication
Schizophrenia
indication
Schizo Affective Disorder
indication
Schizophrenia
indication
investigator
Michael Francis, MD
person